Literature DB >> 412808

The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.

W Dobrzecki, A Kaczmarek.   

Abstract

In order to reduce the recurrence rate of bladder tumours, 78 patients with bladder tumours have been treated since November 1973 with topical Thio-TEPA bladder instillations. This method was used as an adjuvant to other forms of therapy. At the time of this review 20 of the patients have been followed up for at least one year following the onset of Thio-TEPA treatment. The total number of recurrences in these patients seems to be reduced. Advantages of topical therapy and indications for treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412808     DOI: 10.1007/bf02082016

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  23 in total

1.  REPORT OF A FOLLOW-UP OF PAPILLARY TUMOURS OF THE BLADDER.

Authors:  L N PYRAH; F P RAPER; G M THOMAS
Journal:  Br J Urol       Date:  1964-03

2.  Thiotepa in the treatment of tumours of the bladder.

Authors:  H C JONES; J SWINNEY
Journal:  Lancet       Date:  1961-09-16       Impact factor: 79.321

3.  Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy.

Authors:  M M MELICOW
Journal:  J Urol       Date:  1952-07       Impact factor: 7.450

4.  The association of urothelial atypism with neoplasia: its importance in treatment and prognosis.

Authors:  R O Schade; J Swinney
Journal:  J Urol       Date:  1973-04       Impact factor: 7.450

5.  The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers.

Authors:  J E Drew; V F Marshall
Journal:  J Urol       Date:  1968-06       Impact factor: 7.450

6.  Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder.

Authors:  A Abbassian; D M Wallace
Journal:  J Urol       Date:  1966-10       Impact factor: 7.450

7.  Papilloma of the urinary bladder.

Authors:  R I Lerman; R V Hutter; W F Whitmore
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

8.  Optimal intravesical dosage of thio-tepa in the prophylaxis of recurrent bladder papillomatosis.

Authors:  K J Oravisto
Journal:  Scand J Urol Nephrol       Date:  1972

9.  [Verification of the effectiveness of Thio-Tepa on tumor tissue in local chemotherapy of bladder papillomatosis].

Authors:  G Lunglmayr; G Kellner; K Czech
Journal:  Urol Int       Date:  1970       Impact factor: 2.089

10.  Instillation of thio-tepa (Tifosyl) in vesical papillomatosis.

Authors:  F Edsmyr; J Boman
Journal:  Acta Radiol Ther Phys Biol       Date:  1970-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.